I'll research CF Industries before writing the preview. Let me gather recent earnings materials, filings, and news.Let me read the most recent earnings materials and check for recent news and filings.Let me get recent news, press releases, and stock price data to round out the picture.Let me read the dividend increase press release and check recent sector/company news.I have what I need. Let me write the preview.
Report date: Results after market close Wed, Aug 5, 2026 · Conference call Thu, Aug 6, 11:00 a.m. ET Recent price: ~$118 (Aug 4) · YTD: ~+47% off a $80 start, but ~14% below the ~$137 mid-March peak
This is the print that should capture the full-quarter benefit of the Middle East supply shock. Q1 caught only the tail end of the Iran conflict/Strait of Hormuz disruption (late March), yet CF still put up $983M adjusted EBITDA and $3.98 EPS (albeit aided by a ~$170M litigation gain). Q2 is CF's seasonally strongest quarter and the first to reflect both peak North American spring pricing and the post-shock spike in global nitrogen — while natural gas costs were collapsing. The key debate isn't whether Q2 was strong; it's how much of the geopolitical windfall shows up, and whether management can convince investors the tightness is durable into 2027 rather than a one-off.
This is where the stock is really traded. Management's thesis: the Iran conflict is the third major nitrogen supply shock in six years and structurally lifts mid-cycle economics ("the CF premium"). Key data points to update: - China exports — expected to restart on a limited basis late Q2; the market needs "all of China and more" to balance, per Frost. - India — potential 10–12M mt of urea imports in 2026 (near double 2024); watch tender cadence/pricing. - Egypt's ~$90/mt export duty, Russia restrictions, and ongoing LNG-driven curtailments in India/Pakistan/Bangladesh. - Management's claim that the market stays tight through 2026 and into 2027 is the linchpin for the bull case. Any softening in that language would be a red flag given the stock's June pullback to ~$105.
| Metric | Q1 2026 | Q1 2025 | Note |
|---|---|---|---|
| Net sales | $1.99B | $1.66B | Higher prices, lower volumes |
| Adj. EBITDA | $983M | $644M | Q1'26 incl. ~$170M litigation gain |
| Diluted EPS | $3.98 | $1.85 | |
| Realized gas | $4.57 | $3.68 | Q2 gas set to fall sharply |
| Ammonia utilization | 99% | — | ex-Yazoo City |
| TTM FCF | $1.65B | $1.57B | industry-leading conversion |
Modeling note: Q1's headline was flattered by the ~$170M/$129M after-tax litigation settlement plus $24M of 45Q credits and $25M insurance recoveries. Strip those out for a cleaner read on the underlying trajectory into Q2. Also remember the drag from noncontrolling interests (CHS distribution ~$88M/qtr accrual, plus the consolidated Blue Point JV).
Q2 should be a strong, potentially standout quarter on the collision of peak-season demand, a full quarter of shock-elevated global prices, and a big drop in natural gas costs — and the 20% dividend hike telegraphs management's confidence. The report will likely hinge less on the beat itself and more on three things: (1) how aggressively CF redeploys its cash windfall into buybacks after a nearly dormant Q1, (2) the durability of the "higher-for-longer" nitrogen narrative into 2027 (China/India/LNG dynamics), and (3) any change to the Yazoo City restart timeline. With the stock having round-tripped from its March highs, the forward commentary — not the quarter — is what moves it.
Sources: CF Q1 2026 earnings release and call transcript (May 6–7, 2026); CF dividend press release (July 8, 2026); daily price data through Aug 4, 2026.
Want me to pull consensus estimates or build a quick sensitivity on Q2 EBITDA under different urea price/gas cost scenarios?